MP48-10 INCLUSION OF THE “EXTREME” ANTERIOR APICAL NEEDLE BIOPSIES IN THE STANDARD 12 CORE BIOPSY TEMPLATE AT THE INITIAL DETECTION OF PROSTATE CANCER

CONCLUSIONS: TPMB found significant cancer in 81.4% (48/ 59). It also identified the subgroups with very high risk features (positive PI and SVI). Positive TPMB is not influenced by prior negative TRUS biopsy. TPMB might be considered as the first biopsy approach, especially in higher risk patients with a positive family history or abnormal DRE. The performance of TPMB should be prospectively compared to mpMRI to determine which technique yields more accurate information.